Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma

Background: Angiogenesis inhibitors have become an important therapeutic approach in the treatment of hepatocellular carcinoma (HCC) patients. The therapeutic inhibition of angiogenesis of Sorafenib in increasing overall survival of patients with HCC is a fundamental element of the treatment of this...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Front Pharmacol
मुख्य लेखकों: Berretta, Massimiliano, Rinaldi, Luca, Di Benedetto, Fabrizio, Lleshi, Arben, De Re, Vallì, Facchini, Gaetano, De Paoli, Paolo, Di Francia, Raffaele
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Frontiers Media S.A. 2016
विषय:
Pharmacology
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5101236/
https://ncbi.nlm.nih.gov/pubmed/27881963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00428
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन